ArticleOncogenesis2018

Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer.

Xiaohong Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.